ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 0067 • ACR Convergence 2022

    Cost Per Responder in RA Patients Failing First Line Treatment

    Manuel Cardozo, Pharmalab PHL, Huixquilucan, Mexico

    Background/Purpose: The Colombian healthcare system is under economic pressure like many other systems in the world. In that sense, treatment choice involves cost in addition…
  • Abstract Number: 0119 • ACR Convergence 2022

    Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions Varies by Geographic Location of Residence

    Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Steven Katz2, Eileen Davidson3, Clare Hildebrandt4, Katie Lin1, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

    Background/Purpose: Rheumatology services in Canada are largely restricted to urban centres, resulting in significant access difficulties for residents of rural and remote locations. As a…
  • Abstract Number: 1272 • ACR Convergence 2022

    Application of the Consolidated Framework for Implementation Research (CFIR) to Study Top-Performing Practices in the RISE Registry

    Lindsay Jacobsohn1, Catherine Nasrallah2, Cammie Young3, Gabriela Schmajuk4 and Jinoos Yazdany5, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, 3University of California San Francisco, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA, 5UCSF, San Francisco, CA

    Background/Purpose: Collection and use of rheumatoid arthritis (RA) disease activity and functional status outcome measures facilitates treating-to-target and shared decision-making. Although guidelines recommend regular use…
  • Abstract Number: 0068 • ACR Convergence 2022

    Differential Diagnostic Coding Patterns and Associated Sociodemographic Factors in Childhood-Onset Lupus Nephritis

    Emily Smitherman1, Rouba Chahine1, Aimee Hersh2 and Jeffrey Curtis3, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Utah, Salt Lake City, UT, 3University of Alabama at Birmingham, Hoover, AL

    Background/Purpose: Disparities in long-term kidney outcomes have been documented in patients with childhood-onset systemic lupus erythematosus (cSLE) complicated by lupus nephritis (LN). However, there remains…
  • Abstract Number: 0121 • ACR Convergence 2022

    Rheumatoid Arthritis Care Experiences of Black People Living in Canada: A Qualitative Study to Inform Treatment Guidelines

    Megan Thomas1, Cheryl Barnabe2, Tessa Kleissen2, Diane Lacaille3, Glen Hazlewood2, Nejat Hassen4, Richard Henry5, Kelly English6, Michael Kuluva7, Aurore Fifi-Mah2 and Nicole Johnson2, 1University of British Columbia, Vancouver, BC, Canada, 2University of Calgary, Calgary, AB, Canada, 3Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 4University of British Columbia, Arthritis Research Canada, RICHMOND, BC, Canada, 5McGill University, Montréal, QC, Canada, 6Arthritis Patient Advisory Board of Arthritis Research Canada, Vancouver, BC, Canada, 7Creaky Joints, Vancouver, BC, Canada

    Background/Purpose: Guidelines may unintentionally introduce inequities in care through recommendations that do not reflect the realities of healthcare access and quality for persons who are…
  • Abstract Number: 1291 • ACR Convergence 2022

    Development and Pilot Implementation of a Predictive Model to Identify Visits Appropriate for Telehealth

    david leverenz1, Mary Solomon1, Nicoleta Economau-Zavlanos1, Bhargav Srinivas Adagarla2, Theresa Coles1, Isaac Smith3, Robert Overton1, Catherine Howe3, Jayanth Doss4, Ricardo Henao1 and Megan Clowse4, 1Duke University School of Medicine, Durham, NC, 2Duke Clinical Research Institute, Durham, NC, 3Duke University Hospital, Durham, NC, 4Duke University, Durham, NC

    Background/Purpose: Since January 2021, providers in our practice have used the Encounter Appropriateness Score for You (EASY) to document their perception of the appropriateness of…
  • Abstract Number: 0070 • ACR Convergence 2022

    Post-operative Delirium and Cognitive Impairment: An Analysis of Predictors and 120-day Outcomes in England Using the National Hip Fracture Database (NHFD)

    Samuel Hawley1, Dominic Inman2, Celia Gregson1, Michael Whitehouse1, Antony Johansen3 and Andrew Judge1, 1University of Bristol, Bristol, United Kingdom, 2Northumbria Healthcare NHS Foundation Trust, Northumbria, United Kingdom, 3Cardiff University, Cardiff, Wales, United Kingdom

    Background/Purpose: Post-operative delirium and cognitive impairment are common after hip fracture. We set out to identify risk factors and examine the association with returning home…
  • Abstract Number: 0195 • ACR Convergence 2022

    Acceptance of Virtual Reality for Managing Their Disease Among People with Rheumatologic Conditions with and Without Prior Experience Using Virtual Reality

    Jeffrey Curtis1, Kimberly Garza2, Cassie Clinton3, Heqin Yang2, Alexicia Richardson2, Cheryl Seals2, Gary Hawkins2, Chad Rose2, William Benjamin Nowell4, Kelly Gavigan5 and Liana Fraenkel6, 1Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Auburn University, Auburn, AL, 3University of Alabama at Birmingham, Hoover, AL, 4Global Healthy Living Foundation, Nyack, NY, 5Global Healthy Living Foundation, Upper Nyack, NY, 6Berkshire Medical Center, Lenox, MA

    Background/Purpose: We aimed to assess enthusiasm for the use of virtual reality (VR) for clinical and educational use among people with rheumatologic diseases, comparing those…
  • Abstract Number: 1312 • ACR Convergence 2022

    Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed by Alendronate in US Men at High Risk of Fracture

    Mickael Hiligsmann1, Stuart Silverman2, Andrea J Singer3, Leny Pearman4, jake Mathew4, Yamei Wang4, John Caminis4 and Jean-Yves Reginster5, 1Maastricht University, Maastricht, Netherlands, 2Cedar-Sinai Medical Center and UCLA School of Medicine, Los Angeles, CA, 3MedStar Georgetown University Hospital, Washington, DC, 4Radius Health, Inc., Waltham, MA, 5University of Liège, Liège, Belgium

    Background/Purpose: Previous cost-effectiveness analyses in postmenopausal women (PmW) with osteoporosis (OP) demonstrated that sequential treatment with abaloparatide (ABL) followed by alendronate (ALN) resulted in lower…
  • Abstract Number: 0072 • ACR Convergence 2022

    Geographical Patterns of Healthcare Utilization Among RA and OA Patients

    Sofia Pedro1, Luke Desilet2, Patricia Katz3 and Kaleb Michaud2, 1Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 2University of Nebraska Medical Center, Omaha, NE, 3UCSF, San Rafael, CA

    Background/Purpose: Rural residence has been associated with disparities in healthcare-related outcomes in both rheumatic diseases and other chronic conditions. A primary causal pathway for this…
  • Abstract Number: 0402 • ACR Convergence 2022

    Opioid Use and Healthcare Utilization in Adults with PsA and AS

    Alexis Ogdie1, Sofia Pedro2, Jean Liew3 and Kaleb Michaud4, 1Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3Boston University, Boston, MA, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Opioid use among individuals with spondyloarthritis is common, reported to be ~20-30% in some cohorts. Data on whether this subset of patients have higher…
  • Abstract Number: 1488 • ACR Convergence 2022

    Incremental Healthcare Resource Utilization and Costs of Herpes Zoster in Patients with Psoriatic Arthritis: A Retrospective Cohort Study

    David Singer1, Philippe Thompson-Leduc2, Siyu Ma3, Deepshekhar Gupta4, Wendy Cheng5, Selvam Sendhil6, Manasvi Sundar6, Ella Hagopian5, Mei Sheng Duh7 and Sara Poston1, 1GSK, Philadelphia, PA, 2Analysis Group, Inc., Montréal, QC, Canada, 3GSK/Tufts Medical Center, Boston, MA, 4Analysis Group, Inc., Menlo Park, CA, 5Analysis Group, Inc., Boston, MA, 6Analysis Group, Inc., Los Angeles, CA, 7Analysis Group Inc, Boston, MA

    Background/Purpose: Patients with psoriatic arthritis (PsA) may be at increased risk of herpes zoster (HZ). HZ can involve a painful dermatomal rash and lead to…
  • Abstract Number: 0074 • ACR Convergence 2022

    Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Costs in Patients with Systemic Lupus Erythematosus (SLE) in the US

    Prajakta Masurkar1, Jennifer Reckleff2, Nicole Princic3, Brendan Limone4, Hana Schwartz4, Elaine Karis5, Eric Zollars6, Bradley Stolshek5 and Karen Costenbader7, 1Amgen, Wylie, TX, 2Amgen, Westlake Village, CA, 3IBM Watson Health, Reading, MA, 4IBM Watson Health, Bethesda, MD, 5Amgen, Inc., Thousand Oaks, CA, 6Amgen, Newbury Park, CA, 7Brigham and Women's Hospital, Boston, MA

    Background/Purpose: SLE treatment is complex, with a wide variety of medications commonly prescribed. Limited evidence exists in the literature with respect to treatment patterns, HCRU…
  • Abstract Number: 0463 • ACR Convergence 2022

    Utilization of a Giant Cell Arteritis Fast-Track Program Independent of Ultrasound at a Single Center

    Christina Costeas, Shubhasree Banerjee, Madhura Tamhankar, Naomi Amudala, Peter Merkel and Rennie Rhee, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The Giant Cell Arteritis (GCA) Fast-Track program was implemented at our center with the goal of accelerating diagnosis of this rare and rapidly progressive…
  • Abstract Number: 1774 • ACR Convergence 2022

    Performance of an Early Triage System for Identification of Patients with Inflammatory Rheumatic Diseases

    Xenofon Baraliakos1, Imke Redeker2, Maria Zacharopoulou2, Styliani Tsiami3 and Juergen Braun4, 1Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Herne, Ruhr-University Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: The preselection of patients with suspicion of an inflammatory rheumatic disease is not easy for general practitioners and orthopedists. In countries with a limited…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology